Research at University Health Network
Technology Transfer
Menu Level 3  
  Find a ...

 centre or program

  Quick Links
   Read research news
 View maps & directions
 Start a career with us
 Good Clinical Research Practice: Principles e-learning program
 Clinical Research Quality
 Office of Research Trainees
 CAPCR website

  Remote Tools & Access
   Staff Remote Access
 Research Webmail
 SecureDoc Viewers
 CAPCR Remote Login

Subscribe to UHN Research's RSS feed:


Princess Margaret Cancer Institute Techna Institute Toronto General Research Institute Toronto Rehabilitation Institute Toronto Western Research Institute

Princess Margaret Cancer Centre

Techna Institute

Toronto General Research Institute

Toronto Rehab Institute

Toronto Western Research Institute

  • Research foci: cancer— genomics, informatics, molecular biology, clinical trials, signalling pathways, structural biology and biophysics.
  • 376 scientists and clinician-scientists
  • $150M external funding
  • more

  • Headquartered at the Banting Building
  • Research foci: guided therapeutics, informatics and communication technologies, nanotechnology and radiochemistry, photonics, design and engineering for health
  • 50 scientists and clinician-scientists
  • more

  • Located at the Toronto General Hospital
  • Research foci: cardiology, transplantation, immunology and infectious disease
  • 256 scientists and clinician-scientists
  • $74M external funding
  • more

  • Located at Toronto Rehab
  • Research foci: rehabilitation sciences, cardiopulmonary fitness and mobility
  • 118 scientists and clinician-scientists
  • $9M external funding
  • more

  • Located at the Toronto Western Hospital
  • Research foci: Neural and visual sciences, musculoskeletal disease and community and population health
  • 161 scientists and clinician-scientists
  • $37M external funding
  • more

Cancer: Size Matters for Blood Clots
Mar 30, 2015

Patients who develop cancers that arise from reproductive cells—known as germ cell tumours (GCTs)—are at an increased risk of developing blood clots in their veins after they receive chemotherapy. As a result they are more likely to develop medical complications that could lead to hospitalization or death.

While treatment guidelines suggest that patients with cancers can be treated with blood thinners to reduce the risk of blood clots, there is insufficient data available to support the use of this treatment in patients with GCTs. Furthermore, there is currently no way to identify patients with GCTs who are at the highest risk of developing blood clots.

To address this problem Dr. Philippe Bedard and collaborators asked whether the size of secondary cancers that spread from GCTs to the lymph nodes could accurately predict blood clot risk.

Full Story

Cancer: Reducing Aggressive Care with Palliative Care
Mar 27, 2015

Pancreatic cancer is devastating—most patients with this disease suffer from symptoms that require hospitalization and the disease is associated with high mortality rates. For this reason, their quality of life near death and the quality of care that they receive is important. Aggressive care near death for patients with incurable cancers is an important indicator of end-of-life quality; it has been linked with worse quality of life for patients and worse bereavement adjustment for their caregivers.

A study by a team led by PM Cancer Centre’s Dr. Raymond Jang examined whether palliative care (PC) impacts the aggressiveness of the medical care that patients with advanced pancreatic cancer receive near death.

Full Story

The ORT Times March Issue Now Available
Mar 25, 2015

The UHN Office of Research Trainees (ORT) is proud to announce the March 2015 issue of The ORT TimesThe ORT Timesis a monthly e-newsletter focused on UHN trainees featuring news and editorials about trainee life, articles to help developing researchers get the most out of their training experience at UHN, tips on career development, and research training opportunities within and outside of UHN.


Highlights from the March issue:

Lead Article: The changing landscape of CIHR funding

Conference Reports:  Learn what new developments are happening within the fields of neuroscience, epigenetics and cancer, and lysosomal diseases.

Latest & Greatest: Repairing the foundation: hydrogels for heart healing. 

Click here to read and download the full March 2015 issue now!

Full Story


Home Researchers Facilities Support Services Programs Commercialization Ethics News About UHN Institutes OCI Techna TGRI TRI TWRI hyperlink to UHNResearchnews Facebook page hyperlink to UHNResearch Twitter feed